Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Freire

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Analytical Biochemistry|December 8, 2014
Isothermal chemical denaturation to determine binding affinity of small molecules to G-protein coupled receptorsPatrick Ross, Wilhelm Weihofen, Fai Siu, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparumTakuya Miura, Koushi Hidaka, Yukiko Azai, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitutionTakuya Miura, Koushi Hidaka, Tsuyoshi Uemura, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsinKoushi Hidaka, Tooru Kimura, Adam J Ruben, et al.
Chemmedchem|August 3, 2010
The active core in a triazole peptide dual-site antagonist of HIV-1 gp120Muddegowda Umashankara, Karyn McFadden, Isaac Zentner, et al.
Biochemistry|May 30, 2002
Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b siteCynthia S Dowd, Stephanie Leavitt, Gregory Babcock, et al.
Biomaterials|May 1, 2018
Bioinspired supramolecular engineering of self-assembling immunofibers for high affinity binding of immunoglobulin GYi Li, Lye Lin Lock, Yuzhu Wang, et al.
Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.
ACS Nano|August 25, 2015
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in VivoQingguo Xu, Laura M Ensign, Nicholas J Boylan, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studiesPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Analytical Biochemistry|December 8, 2014
Isothermal chemical denaturation to determine binding affinity of small molecules to G-protein coupled receptorsPatrick Ross, Wilhelm Weihofen, Fai Siu, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparumTakuya Miura, Koushi Hidaka, Yukiko Azai, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitutionTakuya Miura, Koushi Hidaka, Tsuyoshi Uemura, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsinKoushi Hidaka, Tooru Kimura, Adam J Ruben, et al.
Chemmedchem|August 3, 2010
The active core in a triazole peptide dual-site antagonist of HIV-1 gp120Muddegowda Umashankara, Karyn McFadden, Isaac Zentner, et al.
Biochemistry|May 30, 2002
Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b siteCynthia S Dowd, Stephanie Leavitt, Gregory Babcock, et al.
Biomaterials|May 1, 2018
Bioinspired supramolecular engineering of self-assembling immunofibers for high affinity binding of immunoglobulin GYi Li, Lye Lin Lock, Yuzhu Wang, et al.
Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.
ACS Nano|August 25, 2015
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in VivoQingguo Xu, Laura M Ensign, Nicholas J Boylan, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studiesPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
Pageof 11